Samantha Lynn Inc. is voluntarily recalling 500 lots of Reumofan Plus Tablets to the consumer level due to findings of undeclared drug ingredients. The Food and Drug Administration (FDA) sample analysis has found the product to contain methocarbamol and diclofenac.
This is a summary of a recall issued by the Food and Drug Administration (FDA). The link below will take you to the original recall press release containing complete information, including instructions about what to do if you are affected by this recall.
View Full Details Of Original FDA Recall Notice Here.
